Halozyme Therapeutics Inc... (HALO)
undefined
undefined%
At close: undefined
48.00
0.04%
After-hours Dec 13, 2024, 05:19 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01
Revenue 829.25M 660.12M 443.31M 267.59M 195.99M 151.86M 316.61M 146.69M 135.06M 75.33M 54.80M 42.33M 56.09M 13.62M 13.67M 8.76M 3.80M 981.75K 127.21K - 25.70K 87.77K 24.68K
Cost of Revenue 192.36M 139.30M 81.41M 43.37M 45.55M 10.14M 31.15M 33.21M 29.25M 22.73M 6.25M 1.09M 257.83K 985.28K 311.89K 332.32K 240.43K 436.99K 51.97K - 27.00K 49.67K 15.86K
Gross Profit 636.89M 520.81M 361.90M 224.23M 150.45M 141.73M 285.46M 113.48M 105.81M 52.60M 48.55M 41.23M 55.83M 12.64M 13.36M 8.43M 3.56M 544.76K 75.24K - -1.30K 38.09K 8.83K
Operating Income 337.57M 267.53M 275.90M 144.25M -67.61M -69.33M 81.00M -83.21M -27.45M -63.04M -80.43M -53.63M -19.84M -54.26M -58.46M -50.43M -28.15M -15.58M -13.56M -9.09M -79.09K -39.39K -39.71K
Interest Income - 15.90M 6.42M 14.95M 7.11M - - - - - - 73.44K - 49.02K 97.74K 1.72M - - - - - - -
Pretax Income 348.33M 248.92M 248.52M 129.30M -72.25M -79.79M 61.61M -101.86M -32.23M -68.38M -83.48M -53.55M -19.77B -53.24M -58.36M -48.72M - - -13.28M -9.09M - -64.46K -39.65K
Net Income 281.59M 202.13M 402.71M 129.09M -72.24M -80.33M 62.97M -103.02M -32.23M -68.38M -83.48M -53.55M -19.77M -53.24M -58.36M -48.65M -23.90M -14.75M -13.28M -9.09M -79.09K -65.26K -39.65K
Selling & General & Admin 149.18M 143.53M 50.32M 45.74M 77.25M 60.80M 53.82M 45.85M 40.03M 35.94M 32.35M 24.81M 18.10M 15.12M 15.20M 14.63M 11.16M 6.91M 3.42M 2.57M 77.79K 350.00 48.53K
Research & Development 76.36M 66.61M 35.67M 34.24M 140.80M 150.25M 150.64M 150.84M 93.24M 79.70M 96.64M 70.04M 57.56M 51.77M 56.61M 44.23M 20.55M 9.21M 10.22M 6.52M - - -
Other Expenses 73.77M 43.15M - - - - - - - - - 14.42K 257.83M - - - - - - - - 77.13K -
Operating Expenses 299.32M 253.28M 86.00M 79.97M 218.06M 211.06M 204.46M 196.69M 133.26M 115.64M 128.99M 94.86M 75.67M 66.90M 71.82M 58.87M 31.71M 16.13M 13.64M 9.09M 77.79K 77.48K 48.53K
Interest Expense 18.76M 16.95M 7.53M 20.38M 11.63M 18.04M 21.98M 19.98M 5.20M 5.58M 3.27M - - - - - - - - - - - -
Selling & Marketing Expenses - - - - - - - - - - - - - - - - - - - - - 350.00 1.12K
Cost & Expenses 491.68M 392.58M 167.41M 123.34M 263.60M 221.19M 235.61M 229.90M 162.51M 138.37M 135.23M 95.95M 75.93M 67.88M 72.13M 59.20M 31.95M 16.56M 13.69M 9.09M 104.80K 127.16K 64.39K
Income Tax 66.73M 46.79M -154.19M 217.00K -11.00K 537.00K -1.36M 1.16M 3.52M 3.82M 2.05M -1.14M -1.16M -1.02M - -63.00K -4.25M -830.87K -286.04K 3.53K 79.09K 800.00 -
Shares Outstanding (Basic) 131.93M 136.84M 140.65M 136.21M 144.33M 143.45M 136.42M 127.19M 126.70M 122.69M 112.81M 111.08M 102.57M 94.36M 86.70M 79.84M 74.32M 62.61M 50.32M 35.41M 6.83M 4.60M 1.20M
Shares Outstanding (Diluted) 134.20M 140.61M 146.80M 141.46M 144.33M 143.60M 139.07M 127.96M 126.70M 122.69M 112.81M 111.08M 102.57M 94.36M 86.70M 79.84M 74.32M 62.61M 50.32M 35.41M 6.83M 4.60M 1.20M
EPS (Basic) 2.13 1.48 2.86 0.95 -0.5 -0.56 0.46 -0.81 -0.25 -0.56 -0.74 -0.48 -0.19 -0.56 -0.67 -0.61 -0.32 -0.24 -0.26 -0.26 -0.01 -0.01 -0.03
EPS (Diluted) 2.10 1.44 2.74 0.91 -0.5 -0.56 0.45 -0.81 -0.25 -0.56 -0.74 -0.48 -0.19 -0.56 -0.67 -0.61 -0.32 -0.24 -0.26 -0.26 -0.01 -0.01 -0.03
EBITDA 451.95M 315.51M 259.04M 152.96M -56.56M -69.33M 83.16M -79.47M -25.35M -61.03M -78.98M -52.47M -18.67M -52.75M -56.92M -49.39M -28.15M -14.51M -13.36M -8.96M -79.09K -14.31K -39.76K
Depreciation & Amortization 84.86M 49.64M 3.00M 3.28M 4.07M 2.39M 2.16M 2.41M 1.68M 1.76M 1.23M 1.08M 1.10M 1.51M 1.44M 1.05M 576.49K 244.00K 206.35K 123.35K - 25.08K -54

Create Price Alert on HALO

Your price alert will notify you when the stock price is above 47.98.

Add to Watchlist